Background: Studies of the mechanisms by which signals are transmitted from receptor tyrosine kinases would be facilitated by a way of monitoring events at the single-cell level. We have explored how luciferase imaging can be used to examine the role of specific signalling pathways in insulin-stimulated gene expression. The analysis of luciferase expression in single cells has previously been hampered by the insensitivity of existing methodologies and the lack of a way of monitoring quantitatively, and independently, more than one promoter within the same cell. We have developed a technique for examining the dynamics of insulin-stimulated AP-1-dependent transcription in single living cells, and have explored the signalling pathway involved. Results: Luciferase and aequorin gene expression were examined in single living cells with a high-sensitivity photon-counting camera. The technique involved the comicroinjection of luciferase-and aequorin-based reporter plasmids directly into the cell nucleus, and the subsequent analysis of luminescence in the presence of luciferin and coelenterazine, respectively. The method is quantitative and allows insulin-stimulated gene expression to be monitored in real time. We found that insulin promoted a substantial increase in the expression of a luciferase gene under the control of the AP-1-binding site from the collagenase gene promoter. Aequorin expression, under the control of a cytomegalovirus promoter, was unaffected by insulin. The effect of insulin on luciferase expression was specifically blocked by overexpression of either the mitogen-activated protein (MAP) kinase phosphatase CL100, or the dominant-negative mutant MAP kinase kinase,
Background
The use of heterologous reporter genes, such as chloramphenicol acetyltransferase (CAT) and firefly luciferase, has revolutionized studies of the mechanisms involved in transcriptional regulation [1, 2] . However, these studies generally require the transient or stable transfection of cell populations with promoter-reporter constructs, followed by cell lysis and subsequent biochemical analysis of the activity of the reporter protein. This type of approach only provides an averaged measure of transcriptional activity in the cell population and gives no information about the changes occurring within single cells. This problem can .be partially circumvented by fixing and permeabilizing the cells for the immunohistological analysis of reporter gene expression, but this only provides semi-quantitative information. More importantly, neither method allows real-time analysis of reporter gene activity in vivo. In an attempt to overcome these problems, we have devised a method that allows the monitoring of gene expression in single cells in real time, and applied it to the study of insulin-regulated gene expression.
Insulin stimulates the collagenase promoter, an effect mediated by a single 12-O-tetradecanoylphorbol-13-acetate (TPA)-response element, TGA(G/C)TCA, which acts as binding site for the transcription factor AP-1 [3] . AP-1 is a heterodimer of c-Fos and c-Jun (see [4] for review). The collagenase promoter can confer insulininducible expression upon heterologous reporter genes such as CAT and luciferase [3] . The mechanism by which insulin increases the transcriptional activity of AP-1 has not previously been addressed directly.
The amino-terminal domain of c-Jun has been reported to be phosphorylated in vitro on serine residues 63 and 73 by the mitogen-activated protein (MAP) kinase isoforms, Erkl and Erk2 [5] , as well as by the stress-activated MAP kinase (SAPK) and Jun N-terminal kinase NK) [6, 7] , resulting in an increase in its transcriptional activity. Insulin also rapidly increases c-fos transcription [8] , which may also be mediated by MAP kinase [9] , and which could itself lead to an increase in AP-1 activity. However, the involvement of MAP kinase in the activation of AP-1 by any receptor tyrosine kinase-mediated pathway has not yet been directly proven. Rutter 
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Erkl and Erk2 are rapidly activated by insulin (as well as other growth factors and neurotrophins) [10] [11] [12] . This activation is dependent on phosphorylation by MAP kinase kinase (or MEK), a dual specificity protein kinase which phosphorylates MAP kinases on the threonine and tyrosine residues in the conserved sequence ThrGlu-Tyr within their regulatory domains (residues 192-194 in Erkl, and 183-185 in Erk2). Phosphorylation of both residues is required for MAP kinase activation [11, 12] . MEK itself is phosphorylated and activated by Rafl on two serine residues (at positions 217 and 221) [13] . Substitution of these serine residues with alanines generates a dominant-negative mutant form of MEK, MEKS 2 1 7 / 22 1 A, which blocks nerve growth factor-stimulated neurite outgrowth in PC12 cells and transformation of NIH3T3 cells [14] .
MAP kinase can be inactivated by a family of dual specificity threonine/tyrosine phosphatases, which includes human CL100 [15] , its murine homologue 3CH134 [16] , and PAC-1 [17] . CL100 is more than 10 000-fold more active towards phosphorylated MAP kinase than to a number of other phosphotyrosine-and phosphothreonine/phosphoserine-containing proteins and peptides [18] . These dual specificity MAP kinase phosphatases selectively dephosphorylate MAP kinase when overexpressed in cells [16, 17] . Furthermore, expression in intact cells of an enzymatically inactive mutant form of 3CH134 -3CH134C 2 5 8 s, in which cysteine residue 258 has been substituted by serine -promotes its tight association with phosphorylated MAP kinase [16] and, therefore, may also interfere with normal Erkl/Erk2 function. It is not known, however, whether these dual specificity phosphatases are responsible for the rapid return of MAP kinase activity to basal levels that is often seen after initial stimulation by growth factors. Wu et al. [19] and Alessi et al. [20] have both reported evidence that the rapid inactivation phase is independent of CL 100.
Expression of the luciferase gene has previously only been monitored in intact cells when under the control of strong viral promoters [21] [22] [23] . We have now developed a method that allows highly quantitative and non-invasive monitoring of the activity of the growth factor-regulated collagenase promoter. The method is based on the combined use of two well-characterized photoproteins, luciferase and aequorin, which emit light only in the presence of their respective co-factors, luciferin and coelenterazine/Ca 2 + [2, 24, 25] . Using this method, we have found that insulin-stimulated collagenase promoter activity (assayed using luciferase as a reporter) is specifically blocked upon overexpression of either CLI00 or MEKS 2 17 / 22 1 A. The transcriptional activity of a constitutive promoter was simultaneously monitored (using aequorin as a reporter) and found not to be altered by the presence of insulin, CL100 or MEKs 2 1 7 / 2 2 1
A. The data strongly imply that MAP kinase has a direct role in insulin signalling. This method should have wide application to real-time time studies of gene expression and its regulation.
Results

Analysis of insulin-stimulated luciferase gene expression in single cells
We first cloned a fragment of the human collagenase gene promoter, containing a single TPA-response element (TRE), upstream of the firefly luciferase gene to produce the plasmid designated pCol.Luc. In preliminary experiments, CHO.T cells, which have about 5 x 10 5 human insulin receptors per cell, were transiently transfected with pCol.Luc and treated with insulin. The results showed that the effect of insulin on collagenase promoter activity was largely mediated via the TRE for two reasons. Firstly, insulin stimulated to similar extents the activity of a minimal promoter, with just five repeated TRE sequences, and the collagenase promoter (data not shown). Secondly, the level of insulin-stimulated expression of luciferase under the control of a collagenase promoter lacking the TRE was less than 1 % of that produced using the native collagenase promoter (G.A.R., T. Sood andJ.M.T., unpublished observations).
The pCol.Luc plasmid was microinjected into the nuclei of single CHO.T cells, which were then incubated for 16 hours in the absence or presence of insulin. As shown in Figure la , subsequent imaging of the cells in the presence of 1 mM luciferin, using an intensified photon-counting charge-coupled device (CCD) camera, revealed that insulin treatment resulted in a dramatic increase in the luminescence of individual cells. As the CCD camera is capable of discriminating single photon events, the degree of luminescence can be quantified accurately. Furthermore, the signal:noise ratio of the camera is very low. For example, in a typical experiment, with a data acquisition period lasting 15 minutes, the background photon count detected within an area of about 50 Rtm 2 (equivalent to the area of a CHO.T cell) was 0.71 ± 0.35 (mean ± S.E.M.; n = 7 areas). When CHO.T cells were microinjected with pCol.Luc and incubated for 16 hours in the presence of insulin, the luminescence was 771 135 photons per 15 minutes per cell (n = 36 cells); in the absence of insulin the luminescence was 20.5 + 4.2 photons per 15 minutes per cell (n = 9 cells).
We next examined the time course of insulin-stimulated luciferase expression in single cells. Cells microinjected with pCol.Luc were immediately incubated in the continuous presence of insulin and luciferin at 37 °C. Insulin-stimulated luciferase expression could be monitored in real time on the microscope stage (Fig. lb) . Again, the degree of luminescence of each cell could be accurately quantified and plotted (Fig. c) . Luminescence could be detected in some cells after 2-4 hours, and maximal expression was reached in most cells after 20-24 hours (Fig. lb,c; and data not shown). Neither luciferase expression nor the cofactor luciferin had any apparent toxic effect on the cells, which continued to divide (Fig. lb, arrowhead) and exhibit motility on the tissue culture dish (compare images at 12 and 14 hours).
The quantification of the data presented in Figure 1c revealed considerable heterogeneity in the time course of response of individual cells. The cause of this heterogeneity remains to be established but, because the cells were not synchronized, it may be related to cell-cycle effects.
In contrast to these experiments, expression of luciferase could not easily be detected in single cells that were stably or transiently transfected with pCol.Luc using either the DEAE-dextran or electroporation protocols. This presumably reflects the higher plasmid copy number than can be achieved by direct microinjection. We have found that the level of luciferase expressed is closely proportional to the strength of promoter in the microinjected construct. For example, when CHO.T cells were microinjected with identical concentrations of constructs containing the luciferase gene, either under the control of the collagenase promoter or tandem serum response elements (SREs), the ratio of luciferase produced in the presence of insulin was 7:1 (collagenase:SRE). This compares with a ratio of 9:1 when cells were transiently transfected with these same reporter plasmids and standard luminometer-based luciferase assays were performed on the cell extracts.
Effect of CL100 and MEKs
/ 2 21
A on insulin-stimulated collagenase promoter activity CHO.T cells were co-microinjected with pCol.Luc and either a plasmid (pcDNAIneo.CL100) containing the CL100 gene under the control of the strong and constitutively active cytomegalovirus (CMV) promoter, or the control vector (pcDNAIneo). After 16 hours incubation in the presence of insulin, luciferase luminescence was imaged (see Fig. 2a ) and quantified as described above. In the presence of CL100, insulin-stimulated luciferase expression was inhibited by about 75 % -the luminescence of vector-injected cells was 42.1 1.8 photons min -1 per cell (n = 30), and the luminescence of CL100-overexpressing cells was, 10.4 ± 0.6 photons min -1 per cell (n = 21). The phosphatase-inactive mutant form CL1 00 C258s and wild-type CL100 had quantitatively similar effects on insulin-stimulated luciferase expression ( Fig. 2a; CL100C 2 58 s overexpressing, 4.1 0.6 photons min -1 per cell; n = 23). The ability of CL100 to block the insulin effect was specific to the expression of this protein as, for example, the CMV-driven expression of other proteins, such as aequorin (see also below) or 3-galactosidase (data not shown), had no effect on insulin-stimulated collagenase promoter activity. Furthermore, as seen in Figure 2b , neither insulin nor CL100 had any effect on the expression of luciferase from a CMV promoter (which essentially eliminates any effect of insulin on the translation of luciferase mRNA).
It could be argued that CL100 overexpression had a generally toxic effect on cells, which could have led to the decreased effect of insulin on the collagenase promoter that we observed. As CL100 overexpression had no effect on luciferase expression from a CMV promoter (Fig. 2b) , this prospect was unlikely. However, in order to eliminate this possibility, and at the same time to monitor the transcriptional activity of a constitutive promoter, we next co-injected CHO.T cells with plasmids pCol.Luc and pCMV.Aqm. This latter plasmid contains the aequorin gene under the control of the CMV promoter; the encoded aequorin is targeted to mitochondria by an inframe amino-terminal fusion to the signal peptide of cytochrome c subunit VIII [26] . Aequorin chemiluminesces in the presence of its cofactor, coelenterazine, and micromolar concentrations of Ca 2 + ions [25] . Many extracellular stimuli promote a rise in mitochondrial Ca 2 + concentrations to the low micromolar range, significantly higher than cytosolic Ca 2 + concentrations [26, 27] . Thus, aequorin should give a considerably greater photon yield if targetted to the mitochondrion than if cytosolic.
Initial experiments showed that aequorin expression was detectable in single cells after a 4 hour pre-incubation with coelenterazine and treatment with ATP, which stimulates a transient increase in intracellular Ca 2 + upon stimulation of P 2 purinergic receptors (Fig. 3) [28] . The observations). Parallel experiments showed that, in single fura-2-loaded CHO.T cells, ATP raised the cytosolic Ca 2+ concentration from a basal level of 141 + 6.5 nM up to a peak of 360 ± 13.5 nM (mean + S.E.M.; n = 23), which declined to basal values after about 1 minute. Responses to ATP were seen in more than 95 % of stimulated cells. This transient response allowed us subsequently to image luciferase expression upon the addition of luciferin (Fig. 4) .
In cells co-microinjected with pCol.Luc and pCMV.Aqm, insulin stimulated the synthesis of luciferase 22-fold compared to controls, but was without effect on aequorin production in the same cells (Fig. 4) . After co-microinjecting pcDNAIneo.CL100, insulin induction of luciferase synthesis was inhibited by more than 80 %, whereas aequorin production was again essentially unaltered. Calculation of the luciferase to aequorin ratio in individual cells confirmed that CL100 overexpression blocked insulin-stimulated collagenase promoter activity (and, by inference, the AP-1 complex), whereas non-regulated promoter activity was largely unaltered (Table 1) . Similarly, overexpression of MEKS 2 1 7 / 221 A also blocked the ability of insulin to stimulate the activity of the collagenase promoter in CHO.T cells (Table 2) .
We confirmed some of these data by transiently transfecting CHO.T cell populations (Fig. 5 ). Cells were cotransfected with pCol.Luc, pSV.CAT (encoding the CAT reporter under the control of the SV40 promoter) and Overexpression of Erkl enhances the effect of insulin on AP-1 complex activity CHO.T cells were co-transfected with pCol.Luc and pSVCAT along with a plasmid encoding hamster Erkl under the control of the CMV promoter. Overexpression of wild-type Erkl resulted in an approximately two-fold increase in the effect of insulin on luciferase expression (Fig. 6 ). This phenomenon was not observed upon overexpression of a kinase-deficient Erkl (ErklT1 92 A; Fig. 6 ). 2A. Cells were treated for 24 h with or without 100 nM insulin and the resulting luciferase and CAT activities were measured as described in Materials and methods. Data are the means (+ S.D.) from one experiment, performed in duplicate, which was representative of three separate experiments.
Overexpression of either kinase-active or kinase-deficient Erkl had no detectable effect on basal luciferase expression (Fig. 6) .
Effects of insulin and CL100 on MAP kinase translocation to the nucleus
In order to test whether insulin or CL100C 2 5 8 s altered the subcellular distribution of MAP kinase, we co-microinjected CHO.T cells with a plasmid encoding Myc-tagged Erk2 (pEXV.Erk2.myc) and either pcDNAIneo.CL100C 2 58 s or its control, the vector pcDNAIneo. Treatment of the cells with or without insulin followed by fixation, permeabilization and staining with the anti-Myc antibody 9E10 revealed that neither insulin nor the phosphatase-inactive CL100 had any apparent effect on the distribution of Erkl between the cytosol and nucleus (Fig. 7) . Indeed, the antibody revealed considerable nuclear reactivity even in the basal state.
Discussion
In this study, we have developed a novel non-invasive and quantitative assay for monitoring the regulation of transcription by insulin in single living cells. Imaging of firefly luciferase within single living mammalian cells was previously possible only when luciferase was expressed under the control of strong viral promoters [21] [22] [23] . We have now extended these studies to show that luciferase activity can be detected when its expression is controlled by the relatively weak collagenase promoter (which is approximately 100-fold weaker than the CMV promoter; G.A.R. and J.M.T., unpublished observations). Moreover, we have demonstrated that insulin-stimulated luciferase expression can be followed quantitatively in realtime in living cells. Real-time analysis of luciferase gene transcription has also been used in conjunction with an intensified CCD camera (as in our study) to identify circadian clock mutants of Arabidopsis plants [29] .
We have also developed a method that allows the detection of both luciferase and aequorin when expressed simultaneously within single living cells. The ability to quantify the levels of two separate reporter proteins by photon-counting allows changes in the activity of a regulatable promoter to be normalized ratiometrically to that of a constitutive promoter. Thus, the technique offers considerable advantages over current, largely non-quantitative, methods of detecting reporter proteins in fixed and permeabilized cells by immunofluorescence staining. In the present studies, we have analyzed aequorin luminescence purely as a measure of promoter activity. However, the ability to detect Ca 2 +-dependent increases in luminescence from this protein in single cells after its molecular targeting to a specific intracellular compartment will provide a powerful new approach for the analysis of intracellular Ca 2 + signalling and homeostasis.
Our combined microinjection and luminescence imaging approach can, in principle, be used with an almost unlimited array of molecular species -DNA, RNA, peptides, phospholipids, metal ions and so on -that are capable of modulating the activity of specific proteins in known signalling pathways. This, in turn, will permit detailed analysis of the roles that specific signalling pathways play in mediating the effects of a variety of extracellular stimuli on transcription, or even translation of microinjected mRNA species that have regulatable 5' untranslated regions. The technique is also well suited to a real-time in vivo analysis of other phenomena, such as transcriptional regulation during the cell cycle.
We have used this approach to investigate the role of MAP kinase in insulin signalling to the nucleus in living mammalian cells. In vivo evidence in favour of a role for MAP kinase in any action of insulin has hitherto been lacking. Indeed, MAP kinase activation does not appear to be sufficient to account for the metabolic effects of insulin, and so may play a role only in the growthpromoting effects of the hormone (see [30] for recent review). Furthermore, up until now there has been a lack of direct evidence that MAP kinase is involved in the regulation of transcription by any defined receptor tyrosine kinase, although a role for MAP kinases in the action of v-Ras [31] , serum [32] and phorbol esters [17] has been suggested.
We have addressed this issue by using three different approaches to modulate MAP kinase activity: first, inactivating Erkl and Erk2 by overexpressing the phosphatase CL100; second, preventing the activation of Erkl and Erk2 by overexpressing MEKS 2 1 7 / 22 1A; and third, by overexpressing Erkl. When CL100 was overexpressed in CHO.T cells and assayed using single-cell imaging, it was found specifically to block insulin-stimulated collagenase promoter activation without effect on a constitutive, non-regulated CMV promoter. Similar results were obtained when collagenase promoter activation was monitored by transient transfection. Overexpression of CL100, by microinjection of an expression plasmid, did not have a generally deleterious effect on the cell, because the synthesis and luminescence of aequorin, which is highly dependent on cellular ATP concentrations, was largely unaffected. These results are consistent with wild-type CL100 blocking the activation of Erkl/Erk2 by dephosphorylation.
The mutant CL100C 2 5 8 s also blocked the effect of insulin on AP-1-dependent gene expression. The inhibitory effect of CL100C 2 58 s was more evident when the plasmid was microinjected into cells than when it was transiently transfected -this was most likely because microinjection gave higher levels of cellular CL100 expression. At present, this possibility cannot be tested because of the lack of suitable antisera capable of immunostaining CL100 in fixed and permeabilized cells. CL100C 2 58 s has been shown to bind Erkl/Erk2 in vivo [16] and consequently may inhibit kinase activity by preventing the access of substrate (for example, c-Jun) to the kinase active site. The alternative possibility -that the mutant phosphatase may block Erkl/Erk2 translocation into the nucleus -is unlikely, as the distribution of a microinjected, Myctagged Erk2 between the nucleus and cytosol was not affected by overexpressing CL100C 25 8 s (Fig. 7) . Interestingly, unlike other growth factors [33] , insulin does not appear to promote the nuclear translocation of MAP kinase (Fig. 7) , despite a relatively sustained activation of the enzyme in these cells [34] . Thus, net translocation of MAP kinase into the nucleus may not necessarily follow its activation and, furthermore, may not be required for the phosphorylation of transcription factors.
It has been shown previously that CL100 exhibits a considerable degree of substrate specificity for Erkl and Erk2 [18] . In order to exclude further the possibility that the effect of CL100 we observed was due to dephosphorylation of a protein unrelated to the MAP kinases, we used MEKS 21 7 / 2 2 1 A. This protein, which cannot be phosphorylated and activated by Raf-1, blocks growth factor activation of MAP kinases, presumably by sequestering upstream activators of MEK, and possibly MAP kinases themselves [14] . Overexpression of MEKS 2 17 / 221 A did indeed block insulin-stimulated collagenase promoter activity. Furthermore, overexpression of Erkl itself increased the ability of insulin to stimulate the collagenase promoter. Taken together, these data strongly argue for a direct role of MAP kinases in insulin-mediated stimulation of the collagenase promoter Our results are consistent with those of Sun et al. [31] , which showed that the phosphatase 3CH134 blocked the stimulation by activated Ras of increased DNA synthesis and transcription from an SRE. Our results are also consistent with the ability of kinase-inactive Erkl and Erk2 mutants to block the activation of TRE-dependent transcription by thrombin [35] , serum or Ha-Ras [32] . In our experiments, a similar Erkl mutant did not act in a dominant-negative fashion when studied either in transiently transfected cell populations or in single cells co-microinjected with pCol.Luc and pCMV.Aqm (data not shown).
The precise mechanism by which MAP kinase regulates the collagenase promoter (and, by inference, AP-1 activity) in vivo is not known. The inhibition of insulin-stimulated AP-1 activity by CL100 is most simply explained if activated Erkl/Erk2 is required for the phosphorylation of the transcription factor p62TCF/Elk-1 [9] , which may up-regulate c-fos transcription and lead to an increase in the mass of AP-1. However, in some cell types, p62TCF/Elk-1 appears not to play a role in the activation of c-fos expression by insulin [36] . We cannot rule out the alternative possibility that MAP kinases phosphorylate and consequently activate the amino-terminal domain of c-Jun [5] . JNK also phosphorylates the transcriptional activation domain of c-Jun; however, this process is unlikely to play a role in our studies as the JNK activity in CHO.T cells was unaffected by insulin treatment (G. Welsh and C.G. Proud, personal communication). Furthermore, JNK is a poor substrate for 3CH134 [31] . Changes in the phosphorylation of inhibitory sites within the DNA-binding domain of c-Jun by GSK-3 [37] may play a role, because insulin inhibits the activity of GSK-3 by more than 70 % in CHO.T cells [38] and this kinase is phosphorylated and inactivated by p90rk, which is itself activated by Erkl/Erk2 [39] .
The recent cloning and expression of the Aequoria victoria green fluorescent protein (GFP) [40, 41] , and the development of mutants with altered light emission properties [42] [43] [44] , have provided a possible alternative to luciferase for real-time monitoring of gene expression in single cells. GFP requires no added cofactor, which may provide an advantage over the use of luciferase. Currently, however, we have only been able to detect GFP expression in single CHO.T cells when the gene is placed under the control of the strong CMV promoter (G.A.R., J. Burrone and J.M.T., unpublished observations). By contrast, the collagenase promoter is not strong enough to drive detectable levels of GFP expression. Furthermore, the signal:noise ratio for luciferase imaging using the intensified CCD camera (> 2000) is currently superior to that of fluorescence detection of GFP (< 10) when the two reporter genes are expressed in CHO.T cells using identical CMV promoters (G.A.R. and J.M.T., unpublished observations).
The low levels of GFP fluorescence may be a consequence of the slow rates of chromophore formation at the low oxygen tensions present inside cultured mammalian cells [45] . These problems could limit the suitability of GFP as a real-time reporter of gene expression from weak promoters in single mammalian cells. Our studies have shown that the luciferase protein has a half-life of approximately three hours in CHO.T cells .M.T. and G.A.R., unpublished observation; but see also [22] ). Such a turnover rate will make luciferase a highly suitable reporter for monitoring rapid changes in gene expression, for example when using cell-cycle-dependent promoters.
Conclusions
We have developed a non-invasive and quantitative method for the real-time monitoring of regulated gene expression in single living cells. Luciferase imaging, coupled with a microinjection approach, provides the only currently available method that will allow the quantitative analysis of weak, growth factor-or hormone-regulated promoter activities in single living cells. We have used this method to provide the first direct evidence that MAP kinase has a role in insulin signalling to the nucleus.
Materials and methods
Materials
Amersham International (Amersham, UK) provided 14C-acetyl CoA. Oligonucleotides were synthesized by the University of Bristol Molecular Recognition Centre. Beetle luciferin was from Promega (Madison, Wisconsin, USA) and coelenterazine from Molecular Probes (Eugene, Oregon, USA). Unless otherwise stated, all other biochemical reagents were either from Sigma (Poole, Dorset, UK) or BDH (Poole, Dorset, UK).
Reporter plasmids
The plasmid pCol.CAT, containing the 580 base-pair 5' region (-517 to +63) of the human collagenase promoter upstream of the CAT gene [46] , was generously provided by R. Medema. The pCol.Luc plasmid was generated, using standard techniques, by amplifying the 580 base-pair upstream region of the collagenase promoter by PCR, using pCol.CAT as template. The primer sequences used were 5'-TTTTTAG-ATCT& 5 17 )CAGGCAGCTTAACAA (BglII site underlined), and 5'-TTTTTAAGCTT(+ 63 )TGTCTTCTT-3' (HindlII site underlined). The resulting 602 base-pair fragment was bluntended using Klenow DNA polymerase and deoxynucleotide triphosphates, digested with BgllI and HindIII, gel-purified and subcloned into the polylinker BglII and HindIII sites of the luciferase vector, pGL2-basic (Promega, Madison, USA). Automated sequencing (University of Bristol Molecular Recognition Centre) across the insert demonstrated identity with the same portion of the original pCol.CAT plasmid. However, we have noted in the case of both plasmids the presence of an additional guanosine, 61 base pairs upstream of the transcriptional start site, which was not previously reported [3] . Plasmid pCMV.Luc corresponds to plasmid pMW16 of White et al. [22] . The plasmid pSV2.CAT was provided by A. Beckett and plasmid pCMV.Aqm was a gift of R. Rizzuto.
Expression plasmids
Plasmids containing wild-type CL100 or CL100C 2 58s cDNAs in pT500 were provided by S. Keyse Cell culture and microinjection CHO.T cells (0.4 x 106) were seeded on 60 mm diameter petri dishes in Ham's F12 medium (Gibco, Paisley, UK) supplemented with 5 % (v/v) foetal calf serum (FCS; Gibco), 10 mM Hepes-NaOH, 200 U ml-1 benzylpenicillin, 100 p.g ml-1 streptomycin and 250 pg ml-' G418, and cultured at 37 C in an atmosphere of 5 % CO 2 . After 24 h, pCol.Luc (in 2 mM Tris-HCl, pH 8.0, 0.2 mM Na 2 EDTA and at the concentration given in the figure legends), along with other plasmids as required, were microinjected (0.2-2.0 sec injection time and at 60-300 hPa pressure) into CHO.T cells using an Eppendorf 5171 micromanipulator and 5424 pressure injector with micropipettes (0.2-0.5 pm external diameter) pulled from glass borosilicate capillaries (GC120F-10; Clark Biomedical Instruments) and an inverted microscope (Zeiss Aviovert 100TV). Cells were allowed 30 min to recover before incubation with or without insulin in serum-free Ham's F12.
Cell-luminescence imaging
Cell luminescence was measured using the Zeiss Axiovert 100TV microscope with a 10x and 0.5 NA objective and a charge-coupled device camera (C2400-20M; Hamamatsu Photonics, Hamamatsu, Japan) fitted with a two-stage microchannel plate intensifier and Argus-50 image analysis system (Hamamatsu Photonics). Images were collected in the slice and gravity modes; the latter was used for quantification purposes [22] . Aequorin luminescence was measured after preincubation of cells for 4 h the presence of 2.5 I.M coelentererazine (Molecular Probes). Cells were incubated at 37 C in 1 ml modified Kreb's-Ringer bicarbonate [27] and a basal image taken for 1 min. ATP was rapidly added to a final concentration of 20 p.M in a further 1 ml medium during the acquisition of a second image which lasted for 1 min. Luciferase luminescence was then monitored in the presence of 1 mM beetle luciferin and image acquisition performed for the time periods indicated in the figure legends.
Transient transfection of cell populations CHO.T cells (0.4 x 106) were seeded onto 60 mm dishes and incubated for 24 h in Ham's F12 medium containing 5 % FCS. Cells were then transfected for 90 min, using 250 L.g ml-' DEAE-dextran and the concentrations of DNA given in the figure legends, in 3 ml serum-free Ham's F12 medium. Cells were then incubated for 4.5 h in the same medium (minus DEAE-dextran and DNA), supplemented with 5 % FCS and 100 .M chloroquine, and subsequently for 16-20 h in this medium containing 0.5 % FCS and no chloroquine. After preincubation for 1 h in serum-free medium, insulin was added and the culture continued for a further 24 h. Cells were gently scraped into ice-cold phosphate-buffered saline, and the suspension divided (2:1) to provide samples for CAT and luciferase assays. After sedimenting for 4 min at 3 000 x g, the cells destined for the CAT assay were resuspended in 60 I1 of 250 mM Tris-HCI, pH 8.0, 5 mM Na 2 EDTA, freeze-thawed 3 times, and heat treated at 60 °C for 5 min. CAT activity was determined as described [49] . Cells for luciferase assay were resuspended in 25 pl lysiss buffer' (Promega) and enzyme activity determined using a commercially available kit (Promega) and a Lumat LB-9501 luminometer (E.G. and G. Berthold, Bad Wildbad, Germany). The ratio of luciferase activity (photon per ig protein) to CAT activity (dpm per p.g protein) provided a specific measure of collagenase promoter activity corrected for small variations in transfection efficiency.
MAP kinase immunofluorescence CHO.T cells (8 x 104 ml-1) were seeded onto glass coverslips and microinjected with 0.4 mg ml-' of pEXV.Erk2-Myc plus 0.04 mg ml-' of pcDNAlneo or pcDNAIneo.CL100C 2 58 s The cells were incubated for 24 h in Ham's F12 medium containing 5 % FCS and then serum-starved for 2 h prior to incubation for 30 min with 200 nM insulin. The cells were fixed and permeabilized in methanol, blocked with 2 % bovine serum albumin in phosphate-buffered saline and incubated with monoclonal primary anti-Myc antibody 9E10 (1 mg mll [50] ) followed by staining with tetramethylrhodamine isothiocyanate-conjugated goat-anti-mouse immunoglobulin G (1:100; Sigma).
